Home » News » Human Pentraxin3 / TSG-14 (PTX3) ELISA System - A New Inflammation Marker

Archives

News

2009.08.10
Human Pentraxin3 / TSG-14 (PTX3) ELISA System - A New Inflammation Marker

- For research use only -

PTX(1).jpg



 

 

PP-PD03-E0 Human Pentraxin3 / TSG-14 ELISA System

Strong candidate for predicative biomarker for acute coronary syndrome


1.    What is Human Pentraxin 3? / Clinical information

Human Pentraxin3 / TSG-14 (PTX3) is one of the inflammation mediators, which belong to pentraxin family, such as C-reactive protein (CRP) and serum amyloid protein (SAP). It is expected that PTX3 to be a breakthrough biomarker capable of predicting patients' risk of atherosclerosis in the earliest stages.

Detail of PTX3.pdf


2.    What is different from other PTX3 Kit?


Our “Human Pentraxin3 / TSG-14 ELISA System” is superior to following points;


-    Global Standard for PTX3 study
Recently, many PTX3 Kits are available in the world. Each kit indicates different values, because each kit adapts different monoclonal antibodies. But our “Human Pentraxin3 / TSG-14 ELISA System” have been used many clinical researchers, so that “Human Pentraxin3 / TSG-14 ELISA System” will be the global standard of PTX3 study. Especially Prof. Alberto Mantovani, who is the authority of PTX3 study, uphold the value of our PTX Kit.

Publications based on human Pentraxin 3.doc

-    High accuracy
“Human Pentraxin3 / TSG-14 ELISA System” indicates CV only for 0.4 to 3.7%. It is mentioned in this pater (Jump to paper).



3.    Kit specification/ Assay principal / Procedure


Human Pentraxin3 / TSG-14 ELISA System is a solid-phase sandwich immunoassay capable of measuring human PTX3 levels in plasma and serum free cell culture supernatant.


PTX(7).jpg

Instruction of PTX3.pdf

 



4.    Technical Data


PTX(8).jpg

PTX(9).jpg

 

PTX(10).jpg
PTX(11).jpg

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5.  Product Description


Click here




6.    Research Field


-    Inflammation
-    Cardiovascular Disease
-    Acute coronary syndrome
-    Atherosclerosis
It is expected that PTX3 to be a breakthrough biomarker capable of predicting patients' risk of atherosclerosis in the earliest stages.

 

7.   Related products

 

Code# Product Name Package Strage Species Protocol MSDS

Antibodies

Others
PP-PPJ0069-00 PTX3 (anti PTX3 antibody, clone#PPJ0069) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol
PP-PPZ1228-00 PTX3 (anti PTX3 antibody, clone#PPZ1228) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol
PP-PPZ1272-00 PTX3 (anti PTX3 antibody, clone#PPZ1272) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol
PP-PPZ17105-00 PTX3 (anti PTX3 antibody, clone#PPZ17105) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol
PP-PPZ17115-00 PTX3 (anti PTX3 antibody, clone#PPZ17115) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol
PP-PPZ1723-00 PTX3 (anti PTX3 antibody, clone#PPZ1723) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol
PP-PPZ1724-00 PTX3 (anti PTX3 antibody, clone#PPZ1724) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol
PP-PPZ1773-00 PTX3 (anti PTX3 antibody, clone#PPZ1773) 0.1mg/100uL <-20℃ mouse (monoclonal) Protocol

« prev  | Back to index |  next »